Cite
HARVARD Citation
Mirna, M. et al. (2021). Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?. Journal of clinical laboratory analysis. 35 (11), p. n/a. [Online].